Dr Manny Chekol Zewdu, MD - Medicare Internal Medicine in St. Louis, MO

Dr Manny Chekol Zewdu, MD is a medicare enrolled "Hospitalist" physician in St. Louis, Missouri. He went to University Of Louisville School Of Medicine and graduated in 2015 and has 9 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Merced Hospitalist Medical Group Inc, Merced Intensivist Group Inc and his current practice location is 1402 S. Grand, Fdt 14th Floor, St. Louis, Missouri. You can reach out to his office (for appointments etc.) via phone at (314) 577-8762.

Dr Manny Chekol Zewdu is licensed to practice in California (license number A139209) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1881956886.

Contact Information

Dr Manny Chekol Zewdu, MD
1402 S. Grand, Fdt 14th Floor,
St. Louis, MO 63104
(314) 577-8762
Not Available



Physician's Profile

Full NameDr Manny Chekol Zewdu
GenderMale
SpecialityInternal Medicine
Experience9 Years
Location1402 S. Grand, Fdt 14th Floor, St. Louis, Missouri
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Manny Chekol Zewdu attended and graduated from University Of Louisville School Of Medicine in 2015
  NPI Data:
  • NPI Number: 1881956886
  • Provider Enumeration Date: 06/14/2012
  • Last Update Date: 07/06/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3375844533
  • Enrollment ID: I20151223000571

Medical Identifiers

Medical identifiers for Dr Manny Chekol Zewdu such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1881956886NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist A139209 (California)Primary
208M00000XHospitalist 036.139140 (Illinois)Secondary
208M00000XHospitalist 0101259143 (Virginia)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mercy Medical CenterMerced, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Merced Hospitalist Medical Group Inc589094858232
Merced Intensivist Group Inc903253580211

News Archive

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

IRIN examines exclusive breastfeeding practices in Kenya

IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Manny Chekol Zewdu allows following entities to bill medicare on his behalf.
Entity NameRegents Of The Univ Of Ca
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013906973
PECOS PAC ID: 3375456619
Enrollment ID: O20031111000892

News Archive

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

IRIN examines exclusive breastfeeding practices in Kenya

IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Read more Medical News

› Verified 7 days ago

Entity NameLodi Memorial Hospital Association Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1861649352
PECOS PAC ID: 7618880717
Enrollment ID: O20050517000577

News Archive

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

IRIN examines exclusive breastfeeding practices in Kenya

IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Read more Medical News

› Verified 7 days ago

Entity NameMerced Hospitalist Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730431875
PECOS PAC ID: 5890948582
Enrollment ID: O20130108000022

News Archive

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

IRIN examines exclusive breastfeeding practices in Kenya

IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Read more Medical News

› Verified 7 days ago

Entity NameMerced Intensivist Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720604895
PECOS PAC ID: 9032535802
Enrollment ID: O20200811004111

News Archive

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

IRIN examines exclusive breastfeeding practices in Kenya

IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Manny Chekol Zewdu is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Manny Chekol Zewdu, MD
4150 V St, Suite 3400,
Sacramento, CA 95817-1460

Ph: (502) 320-4812
Dr Manny Chekol Zewdu, MD
1402 S. Grand, Fdt 14th Floor,
St. Louis, MO 63104

Ph: (314) 577-8762

News Archive

PET and MR imaging reveals white matter degeneration in Huntington's

Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers - within the context of an Italian-British collaboration - discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease - particularly in the brain's white matter - an area not previously considered primarily involved with the disease.

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

IRIN examines exclusive breastfeeding practices in Kenya

IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

Read more News

› Verified 7 days ago


Hospitalist Doctors in St. Louis, MO

Dr. Sai Prashanth Babu Palepu, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 10018 Kennerly Rd., St. Louis, MO 63128
Phone: 314-208-6000    
Dr. Fadee Abu Al Rub, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: Center For Specialized Medicine, 1225 S Grand Blvd., St. Louis, MO 63104
Phone: 314-257-3760    
Dr. David Andrew Wathen, D.O.
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104
Phone: 314-577-1607    Fax: 314-268-4112

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.